Form 4: NeueHealth CFO Jay Matushak Reports Stock Unit Vesting
SEC Form 4 Filing
Chief Financial Officer of NeueHealth, Jay Matushak, reports the vesting of restricted stock units.
Summary
- On March 6, 2025, Jay Matushak, the Chief Financial Officer of NeueHealth, Inc., reported a transaction involving restricted stock units.
- 6,340 restricted stock units vested, each representing a contingent right to receive one share of NeueHealth's common stock.
- Following the transaction, Matushak directly owns 24,087 shares of common stock and 6,340 restricted stock units.
- The restricted stock units vest in three equal annual installments beginning on March 6, 2024.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted compensation.
Stakeholder Impact
- The vesting of restricted stock units may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Beginning date of the three equal annual installments for vesting of restricted stock units. |
| 03/06/2025 | Date of transaction: vesting of 6,340 restricted stock units. |
| 03/10/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.